Journal
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume 42, Issue 9, Pages 2722-2733Publisher
WILEY
DOI: 10.1002/hed.26158
Keywords
immune escape; immunoediting; NK cell; T cell; tumor heterogeneity
Categories
Funding
- NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000087] Funding Source: NIH RePORTER
- NIDCD NIH HHS [DC000087] Funding Source: Medline
Ask authors/readers for more resources
Background Most current approved or investigational immunotherapeutic approaches for head and neck squamous cell carcinoma are aimed at activating T cells. The majority of patients receiving such immunotherapy do not demonstrate durable tumor remission. Methods Original articles covering tumor heterogeneity, immunoediting, immune escape, and local tumor immunosuppression were reviewed. Results In the face of immune pressure, subclones susceptible to T cell killing are eliminated, leaving behind resistant tumor clones in a process known as immunoediting. Such subclones of tumor cells that are resistant to T cell killing may remain sensitive to natural killer (NK) cell detection and elimination, suggesting that patients harboring such tumors may benefit from combination of T and NK cell-based immunotherapy. Even in the setting of optimal immunotherapy, the immunosuppressive tumor microenvironment may arrogate effector immune responses through a number of distinct mechanisms. Conclusions Highly effective immunotherapy will likely require multimodality approaches targeting independent mechanisms of immune activation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available